Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Ammi visnaga
An ancient Egyptian medicinal herb; khellin inspired the development of amiodarone and sodium cromoglycate; used for asthma, angina, and kidney stones.
Khella (Ammi visnaga) is an ancient Egyptian medicinal herb historically used for asthma, kidney stones, and angina. Its primary active compounds, khellin and visnagin, are furochromones that provide antispasmodic, bronchodilatory, and vasodilatory effects. Modern evidence supports its use for bronchospasm prevention, ureteral stone passage, and mild angina, though clinical data remain limited (Level C).
Khellin and visnagin act as calcium channel blockers and phosphodiesterase inhibitors, leading to smooth muscle relaxation in bronchial, ureteral, and vascular tissues. They inhibit calcium influx via L-type channels and reduce intracellular calcium, while also increasing cAMP levels. This results in bronchodilation, ureteral relaxation facilitating stone passage, and coronary vasodilation. Additionally, flavonoids contribute antioxidant and anti-inflammatory effects.
An ancient Egyptian medicinal herb; khellin inspired the development of amiodarone and sodium cromoglycate; used for asthma, angina, and kidney stones.
Khella (Ammi visnaga) is an ancient Egyptian medicinal herb historically used for asthma, kidney stones, and angina. Its primary active compounds, khellin and visnagin, are furochromones that provide antispasmodic, bronchodilatory, and vasodilatory effects. Modern evidence supports its use for bronchospasm prevention, ureteral stone passage, and mild angina, though clinical data remain limited (Level C).
Khellin and visnagin act as calcium channel blockers and phosphodiesterase inhibitors, leading to smooth muscle relaxation in bronchial, ureteral, and vascular tissues. They inhibit calcium influx via L-type channels and reduce intracellular calcium, while also increasing cAMP levels. This results in bronchodilation, ureteral relaxation facilitating stone passage, and coronary vasodilation. Additionally, flavonoids contribute antioxidant and anti-inflammatory effects.